Co-administration of candesartan with pioglitazone improved inflammatory parameters (HMW-ADN and PAI-1) in hypertensive patients with T2DM of long duration independent of blood pressure changes. This evidence concerns the gene SERPINE1 and type 2 diabetes mellitus.